Knowledge Tree
Relations (1)
related 2.00 — strongly supporting 3 facts
Inflammation is identified as a condition associated with the morbidity of nonalcoholic fatty liver disease [1], with specific inflammatory biomarkers serving as indicators of disease risk [2]. Furthermore, the clinical significance of inflammation in this context is being researched to enhance diagnostic and treatment strategies for the disease [3].
Facts (3)
Sources
Editorial: Inflammation and chronic disease - Frontiers frontiersin.org 3 facts
claimInflammation is associated with the morbidity and mortality of cardiovascular disease, chronic kidney disease, diabetes mellitus, non-alcoholic fatty liver disease, cancer, autoimmune diseases, neurodegenerative disorders, and behavioral health disorders.
claimResearch by Liu et al. suggests that inflammation's clinical significance in nonalcoholic fatty liver disease (NAFLD) may assist in improving diagnosis and treatment options.
claimThe risk of nonalcoholic fatty liver disease (NAFLD) is linearly associated with the inflammation-related biomarkers systemic immune-inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR), and lymphocyte-to-monocyte ratio (LMR), and non-linearly associated with platelet-to-lymphocyte ratio (PLR) when natural logarithm transformed, according to Liu et al.